Professional Documents
Culture Documents
Drugs Affecting The Reproductive System
Drugs Affecting The Reproductive System
Cautions (ESTROGEN)
1. Metabolic bone disease
2. Renal insufficiency
3. Hepatic impairment
4. Breast feeding
Contraindications (PROGESTIN)
1. PID, STD, endometriosis, or pelvic surgery.
2. Drospirenone - risk for hyperkalemia (renal disorders, liver disease, adrenal dysfunction)
Cautions (PROGESTIN)
1. Epilepsy
2. Migraine Headaches
3. Asthma
4. Cardiac or Renal dysfunction
Adverse Effects
Contraindications (FD)
Presence of primary ovarian failure
Thyroid or adrenal dysfunction
Ovarian cysts
Pregnancy
Idiopathic uterine bleeding
Allergy to any fertility drug
Cautions (FD)
Cautions should be used in women who are breastfeeding
Those with thromboembolic (thrombo embolism - a circulating blood clot that gets stuck
and causes an obstruction) disease
With respiratory diseases
Adverse Effects (FD)
Increased risk of multiple births and birth defects
Ovarian overstimulation (abdominal pain, distention, ascites, pleural effusion)
Headache
Gynecomastia (enlargement of a man's breasts)
Nausea (being sick to your stomach)
Bloating
Uterine bleeding
Ovarian enlargement
IV. Uterine Motility Drugs
A. Oxytocics
Stimulate contraction of the uterus, much like the action of the hypothalamus hormone
oxytocin, stored in the posterior pituitary.
• Methylergonovine (Methergine), oxytocin (Pitocin)
Therapeutic Actions and Indications (Oxytocics)
1. Directly affect neuroreceptor site to stimulate contraction of the uterus.
2. Stimulate the lacteal glands in the breast to contract.
3. Indicated for the prevention and treatment of uterine atony after delivery
Pharmacokinetics (Oxytocics)
• Rapidly absorbed after parenteral or oral administration.
• Metabolized in the liver
• Excreted in the urine and feces
• Cross the placenta and enter breast milk
• Administered IM or IV
• Methylergonovine - administered as such directly after delivery and then continued in
the oral
form to promote uterine involution.
• Oxytocin-used in nasal form to stimulate "let down" in lactating women.
Contraindications (Oxytocics)
1. Allergy to oxytocics
2. Cephalopelvic disproportion, unfavorable fetal position, complete uterine atony, or
early pregnancy.
Cautions (Oxytocics)
1. Coronary disease and HPN
2. Previous CS births
3. Hepatic or Renal impairment
Adverse Effects (Oxytocics)
1. Related to excessive effects (uterine hypertonicity and spasm, uterine rupture,
postpartum hemorrhage, decreased FHR)
2. Gl upset (nausea, headache, and dizziness)
3. Methylergonovine - ergotism (n/v, BP changes, weak pulse, dyspnea, chest pain,
numbness and coldness in extremities, confusion, delirium and even coma)
4. Severe water intoxication with coma and maternal death.
B. Abortifacients
Therapeutic Actions and Indications (Abort)
Stimulate uterine activity, dislodging any implanted trophoblasts and preventing
implantation of any fertilized egg
Approved for use to terminate pregnancy at 12 to 20 weeks from the date of the LMP
Pharmacokinetics (Abort)
• Well absorbed when administered.
• Metabolized in liver and excreted in the urine.
• Mifepristone-administered orally and takes 5-7 days to produce the desired effect.
• Carboprost-IM injection, onset of 15 minutes and a duration of 2 hours.
• Dinoprostone-intravaginal suppository, onset of effects in 10 minutes and a duration
of effects of 2 hrs.
Contraindications (Abort)
1. Allergy to abortifacients or prostaglandin
2. After 20 weeks from the last menstrual period
3. Active PID or acute CV, hepatic, renal, or pulmonary disease.
4. Not recommended during lactation.
Cautions (Abort)
1. Caution should be used with any history of asthma, HPN, or adrenal disease.
2. With acute vaginitis (describes various disorders that cause your vagina to become infected) or scarred
uterus.
ANDROGEN
• male sex hormone and includes testosterone and androgens
• testosterone (Durates, Testoderms and others),the primary natural hydrogen
• used for replacement therapy in cases of hypogonadism and to treat certain breast cancers
Pharmacokinetics (ANDROGEN)
• Depot (deep, slow-release) injections, buccal system, topical gels, topical sprays, urethral
pellets and a dermal patch.
• Danazol : synthetic androgen (long-acting) available only in oral form.
• Methyltestosterone and Fluoxymesterone : long half-lives and available in the oral form.
• Well-absorbed and widely distributed throughout the body.
• Metabolize in the liver and excreted in the urine.
Contraindications (ANDROGEN)
1. Any known allergy to the drug or ingredients in the drug
2. During pregnancy and lactation
3. Presence of prostate or breast cancer in men
Cautions (ANDROGEN)
1. Presence of any liver dysfunction or cardiovascular disease
2. The topical forms of testosterone have a black box warning alerting the user to the risk of
virilization in children who come in contact with the drug from touching the clothes and the skin
of the man using the drug
3. Danazol : have black box warning regarding the risk for thromboembolic events, fetal
abnormalities, hepatitis and intracranial HPN